MoonLake Immunotherapeutics's total assets for Q3 2025 were $414.33M, a decrease of -9.95% from the previous quarter. MLTX total liabilities were $123.14M for the fiscal quarter, a 20.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.